Template-guided interstitial implants: Cs-137 reusable sources as a substitute for Ir-192

Area of Science:

• Medical Physics
• Oncology
• Radiotherapy

Background:

• Brachytherapy commonly uses iridium-192 (Ir-192) for gynecologic, rectal, and urologic cancers.
• Iridium-192 is expensive and has a short half-life, necessitating frequent replacements.
• Existing template-guided afterloading systems require flexible, trimmable sources.

Purpose of the Study:

• To develop and evaluate a reusable afterloading system using cesium-137 (Cs-137) as an alternative to Ir-192.
• To compare the physical, dosimetric, and cost-effectiveness of Cs-137 sources with Ir-192 sources.
• To assess radiation protection measures for the new Cs-137 system.

Main Methods:

• Development of a reusable afterloading system with Cs-137 sources.
• Encapsulation of Cs-137 sources in stainless steel tubes for compatibility with standard plastic guide needles.
• Comparison of physical and dosimetric properties of Cs-137 and Ir-192 sources.
• Evaluation of radiation protection and cost-effectiveness.

Main Results:

• The developed Cs-137 sources are compatible with existing Ir-192 afterloading guide needles.
• Physical and dosimetric characteristics of the Cs-137 sources were analyzed and compared to Ir-192.
• Radiation protection and cost-effectiveness analyses were conducted.

Conclusions:

• The reusable Cs-137 afterloading system presents a potentially more cost-effective brachytherapy option.
• This system offers compatibility with established treatment protocols, facilitating adoption.
• Further evaluation is warranted to confirm its clinical efficacy and safety profile.